scispace - formally typeset
V

Virginia S. Taggart

Researcher at National Institutes of Health

Publications -  27
Citations -  2693

Virginia S. Taggart is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Asthma & FEV1/FVC ratio. The author has an hindex of 21, co-authored 27 publications receiving 2589 citations. Previous affiliations of Virginia S. Taggart include Johns Hopkins University & Georgetown University.

Papers
More filters
Journal ArticleDOI

Long-term effects of budesonide or nedocromil in children with asthma.

TL;DR: In children with mild-to-moderate asthma, neither budesonide nor nedocromil is better than placebo in terms of lung function, but inhaled budesonides improves airway responsiveness and provides better control of asthma than placebo or nedOCromil.
Journal ArticleDOI

The relationship of asthma therapy and Churg-Strauss syndrome : NIH workshop summary report

TL;DR: Investigations with the goals of defining the underlying pathophysiologic processes of CSS and establishing the relationships of asthma and its therapies to CSS are needed are needed.
Journal ArticleDOI

Asthma outcomes: quality of life.

TL;DR: Research is strongly recommended to develop and evaluate instruments that provide a distinct, reliable measure of the patient's perception of the impact of asthma on all of the key dimensions of QOL, an important outcome that is not captured in other outcome measures.
Journal ArticleDOI

Cardiovascular risk factor prevention in black schoolchildren: two-year results of the “know your body” program

TL;DR: Results indicated that the "Know Your Body" program may have had a favorable impact on the following risk factors: systolic and diastolic pressures, HDL cholesterol, ratio of total to LDL cholesterol, fitness, fitness (postexercise pulse recovery rate), and smoking.
Journal ArticleDOI

Asthma outcomes workshop: overview.

TL;DR: Standardized outcomes for clinical research in asthma have been proposed and areas in which new outcomes or instruments for their measurement need to be developed and validated are identified.